White powder High Quality weight loss

Retatrutide acetate is a triple agonist peptide for the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R).

Retatrutide acetate inhibits human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643, and 0.775 nM, respectively. It exhibits activity on mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191, and 0.794 nM, respectively.

In vivo, Retatrutide (LY3437943) acetate engages with GCGR and enhances glucose tolerance in an ipGTT by acting through GIP or GLP-1 receptors. Activation via the glucagon receptor by Retatrutide acetate leads to significant weight reduction and increased energy expenditure. Retatrutide acetate can be utilized in research related to obesity.

Mechanism of Action of Retatrutide:

Retatrutide is a multi-target agonist that exerts its effects primarily by activating receptors such as GLP-1 and glucose-dependment insulinotropic polypeptide(GIP) in the body.

Its core effects include:

Appeptide suppression and increased satiety : By acting on the appetite-regulating centers in the brain,it significantly reduces the hunger and decreased food intake.

Delayed gastric emptying : Slows the rate at which food leaves the stomach,prolonging the feeling of fullness and further reducing meal size.

Blood glucose regulation : Promotes insulin secreyion and inhibits glucagon release,hellping to lower blood glucose levels,making it particularly suitable,for patients with type 2 diabetes.